Heart Failure-MERCK 1242-001 (VICTORIA)
The primary aim of this study is to increase the time to first occurrence of cardiovascular (CV) death or heart failure (HF) hospitalization in participants with reduced heart ejection fracture.
Sponsor: Merck Sharp & Dohme Corp.
Indication: Heart Failure
Age: 18 years or older
For more information: https://clinicaltrials.gov/ct2/show/NCT02861534